project |
|
|---|---|
|
Name/scientific name |
IDARUBICIN
|
|
Self-financed or subsidized by the Hospital Authority |
Hospital Authority Drug Formulary
|
|
Indications |
acute myeloid leukemia, acute lymphoid leukemia
|
|
body system |
Cancer and immune system
|
|
type |
Cytotoxic drugs
|
Idarubicin is a drug used to treat leukemia. It belongs to the class of anti-tumor drugs and inhibits the growth of cancer cells by interfering with their DNA replication. Idarubicin is commonly used to treat acute myelogenous leukemia and other forms of leukemia. Patients usually receive this drug intravenously in the hospital, and doctors determine the dose and treatment plan based on the patient's specific condition and type of leukemia. While using Idarubicin, patients may experience some side effects, including nausea, vomiting, hair loss, and thrombocytopenia. If you have any questions or concerns, always seek advice from your doctor. Use this medication exactly as directed by your doctor, and do not change your dose or stop taking it on your own.
Instructions:
IDARUBICIN is an injection that should be given by a healthcare professional in a hospital or clinic. Before use, make sure there is no color change or particle precipitation in the medication. The injection should be done slowly, usually within 15 to 30 minutes. During use, contact with skin should be avoided. If there is accidental spillage, clean it immediately.
Dosage Guidelines:
For most adult patients, the starting dose of IDARUBICIN is 12 mg per square meter of body surface area given once daily for 3 days. Doctors may adjust the dose based on the patient's kidney function and heart condition. For pediatric patients, dosage is usually determined based on their weight and may require more frequent dosage adjustments.
While using IDARUBICIN, patients should follow their doctor's instructions and have regular blood tests to monitor the drug's effectiveness and any potential side effects. During treatment, dosage adjustments or drug discontinuation may be necessary to ensure patient safety and efficacy.
Idarubicin is a chemotherapy drug used to treat leukemia and lymphoma. Its side effects include common discomforts such as dizziness, fatigue, vomiting and diarrhea. Some patients may experience symptoms such as headache, palpitations, and mouth ulcers. Serious side effects include bone marrow suppression, which may lead to anemia, leukopenia, and thrombocytopenia. Some patients may also develop serious heart problems, such as arrhythmia. If any side effects occur, you should consult your doctor immediately.
Drug name: Idarubicin
Taboo:
1. It is prohibited for those who are allergic to Idarubicin or have severe allergic reactions.
2. Patients with heart disease, such as those with a history of cardiac insufficiency, arrhythmia, myocardial infarction, etc. should avoid using Idarubicin.
3. Pregnant and lactating women should avoid using Idarubicin as it may cause harm to the fetus or infant.
4. Patients with hepatic or renal insufficiency should use Idarubicin with caution, and the dose or frequency needs to be adjusted according to the physician's recommendations.
5. Patients who have received cardiac radiation therapy should avoid using Idarubicin to avoid increasing the risk of cardiotoxicity.
6. During the use of Idarubicin, active vaccines should be avoided to avoid affecting the efficacy of the vaccine or causing adverse reactions.
The above are contraindications for Idarubicin. Please carefully evaluate your own condition and follow your physician's instructions before use. If you have any questions or discomfort, you should consult a medical professional immediately.
Idarubicin
Precautions for use: This medication is for use only by physician prescription to treat certain types of leukemia. Please strictly follow your doctor's instructions and do not change the dosage or stop using it on your own. During use, have regular blood tests to monitor effectiveness and possible side effects. If you have any discomfort or concerns, please consult your doctor immediately.
We are the first medical service company in Hong Kong that can complete appointment, communication and payment all through mobile phones. You can easily make an appointment for nursing services through your mobile phone in as little as 3 minutes. The whole process can be done by mobile phone. There is no need to make phone calls and wait for an agency to respond to the selection of medical staff.
traditional care agency
careEASY
Registered Nurse (12 hours)
$3300
$2900(-12%)
Enrolled Nurse (12 hours)
$2900
$2600(-10%)
Health Assistant (12 hours)
$1600
$1200 (-25%)
Transparent fees
Free choice of medical care candidates
Communicate directly with healthcare providers
Single service charge
Credit Card/Apple Pay
Use the drug Idarubicin with special caution during pregnancy. This is an anticancer drug and may cause harm to the fetus. If you are pregnant or plan to become pregnant, tell your doctor right away. Your doctor may recommend that you stop using Idarubicin or switch to another treatment to keep you and your baby safe.
If you become pregnant unexpectedly during treatment, notify your doctor immediately. They will assess the risks and provide appropriate advice based on your specific circumstances.
If you are receiving Idarubicin, you should actively avoid pregnancy and use a reliable method of contraception. At the same time, regular medical examinations should be performed during treatment to monitor your physical condition and pregnancy risks.
In short, Idarubicin should be used with caution and under the guidance of a doctor to ensure the safety of you and your baby. Follow your doctor's advice, get regular checkups, and report any discomfort or unexpected events promptly.
No longer restricted by traditional medical care intermediaries, doctors, nurses and customers also have the right to choose! You can also make remote reservations via mobile phone when you are away from home, no need to call to make reservations for family members!
©2024 All Rights Reserved. Created with LOVE and coffee in 🇭🇰